Medical nutritional therapy on schizophrenic patient with grade 2 obesity and continued antipsychotic drug use

Main Article Content

Andry Kelvianto
Wiji Lestari
Diana Sunardi

Abstract

Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due to multiple factors, including antipsychotic drug consumption. Diet and lifestyle modification remained the firstline modalities for management of obesity in patients with schizophrenia. Metformin  has been recommended for preventing weight gain, including for schizophrenic patients with long-term consumption of psychiatric medication.

Downloads

Download data is not yet available.

Article Details

Section
Articles
Author Biographies

Andry Kelvianto, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital

Department of Nutrition, Faculty of Medicine

Wiji Lestari, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital

Department of Nutrition, Faculty of Medicine

Diana Sunardi, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital

Department of Nutrition, Faculty of Medicine

References

-